FDA Approved: AUSTEDO XR — Original Application (Teva Neuroscience, Inc.)

View source ↗

Summary

FDA approved AUSTEDO XR (deutetrabenazine) from Teva Neuroscience in an original NDA; the extended-release formulation targets symptoms of Huntington's disease …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease
• Tardive Dyskinesia

Drugs mentioned

• AUSTEDO XR (deutetrabenazine)

Snippet

ORIG AP for AUSTEDO XR (DEUTETRABENAZINE)